Drug intelligence / Profile preview

Reconvan + Dipeptiven + Omegaven

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous
01

Overview

This product is a **combination intravenous nutrition regimen** consisting of three separate components: - **Reconvan** (likely a commercial name for a complete or partial parenteral nutrition solution, though very limited specific data are available for this exact name in the literature; based on context and typical hospital usage, likely to be a multi-nutrient PN solution used for baseline calories, macronutrients, and micronutrients) - **Dipeptiven** (a sterile L-alanyl-L-glutamine dipeptide solution, serving as a glutamine source for critically ill or highly catabolic patients, supplementing amino acid solutions in parenteral nutrition)[9] - **Omegaven** (an intravenous fish oil–based lipid emulsion, rich in omega-3 fatty acids [EPA and DHA], indicated as a source of calories and fatty acids primarily for pediatric patients with parenteral nutrition-associated cholestasis [PNAC])[1][3][4][5] This **combination** is designed for specialized parenteral nutrition support, typically for hospitalized patients unable to tolerate or receive enteral nutrition, often in critical care or surgical settings. Mechanisms of action derive from the combined effects: - **Omegaven:** provides anti-inflammatory and immunomodulatory effects through omega-3 fatty acids, supporting liver function and reducing parenteral nutrition–associated cholestasis[1][2][3][4][5] - **Dipeptiven:** delivers glutamine, supporting protein synthesis, immune function, and gut integrity in catabolic states[9] - **Reconvan:** typically provides baseline macro- and micronutrient support (specific composition not available in provided or public sources, but standard for PN solutions)

Brand names
Reconvan + Dipeptiven + Omegaven
Other names
Reconvan + Dipeptiven + Omegaven

Beyond the preview

Go deeper on Reconvan + Dipeptiven + Omegaven.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reconvan + Dipeptiven + Omegaven.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call